These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3358644)

  • 61. Depression in panic disorder and response to alprazolam therapy.
    Pyke RE
    Arch Gen Psychiatry; 1989 Nov; 46(11):1053-4. PubMed ID: 2818142
    [No Abstract]   [Full Text] [Related]  

  • 62. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam.
    Bond AJ; Curran HV; Bruce MS; O'Sullivan G; Shine P
    J Affect Disord; 1995 Dec; 35(3):117-23. PubMed ID: 8749839
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G; Rosenbaum JF
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clonazepam in the treatment of panic disorder and agoraphobia.
    Pollack MH; Rosenbaum JF; Tesar GE; Herman JB; Sachs GS
    Psychopharmacol Bull; 1987; 23(1):141-4. PubMed ID: 3110854
    [No Abstract]   [Full Text] [Related]  

  • 66. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB; Laraia MT; Ballenger JC; Howell EF
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.
    Marks IM; Swinson RP; Başoğlu M; Kuch K; Noshirvani H; O'Sullivan G; Lelliott PT; Kirby M; McNamee G; Sengun S
    Br J Psychiatry; 1993 Jun; 162():776-87. PubMed ID: 8101126
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
    Pecknold JC; Swinson RP
    Psychopharmacol Bull; 1986; 22(1):173-6. PubMed ID: 3726063
    [No Abstract]   [Full Text] [Related]  

  • 69. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
    Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
    J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunological response to stress in agoraphobia and panic attacks.
    Surman OS; Williams J; Sheehan DV; Strom TB; Jones KJ; Coleman J
    Biol Psychiatry; 1986 Jul; 21(8-9):768-74. PubMed ID: 3524696
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
    Carr DB; Sheehan DV; Surman OS; Coleman JH; Greenblatt DJ; Heninger GR; Jones KJ; Levine PH; Watkins WD
    Am J Psychiatry; 1986 Apr; 143(4):483-94. PubMed ID: 2869703
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Switching patients from alprazolam to clonazepam.
    Rosenbaum JF
    Hosp Community Psychiatry; 1990 Dec; 41(12):1302, 1305. PubMed ID: 2276722
    [No Abstract]   [Full Text] [Related]  

  • 74. Continuation treatment of panic disorder with high-potency benzodiazepines.
    Davidson JR
    J Clin Psychiatry; 1990 Dec; 51 Suppl A():31-7. PubMed ID: 2258375
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Drug treatment of panic disorder. Reply to comment by Marks and associates.
    Klerman GL
    Br J Psychiatry; 1992 Oct; 161():465-71. PubMed ID: 1309180
    [No Abstract]   [Full Text] [Related]  

  • 76. Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks.
    Coryell W; Noyes R; Clancy J; Crowe R; Chaudhry D
    Psychiatry Res; 1985 Aug; 15(4):301-11. PubMed ID: 2866558
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
    Sheehan DV
    Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alprazolam in panic disorder: a retrospective analysis.
    Shelton RC; Harvey DS; Stewart PM; Loosen PT
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):423-34. PubMed ID: 8475324
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diazepam versus alprazolam for the treatment of panic disorder.
    Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
    J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The placebo effect in agoraphobia.
    Mavissakalian M
    J Nerv Ment Dis; 1987 Feb; 175(2):95-9. PubMed ID: 2879882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.